Thrivent Financial for Lutherans
KURA icon

Thrivent Financial for Lutherans’s Kura Oncology KURA Stock Holding History

Thrivent Financial for Lutherans’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-58,951
Closed -$521K – 2612
2025
Q3 		$521K Buy
+58,951
New +$420K ﹤0.01% 2062
2025
Q2 		– Sell
-28,748
Closed -$190K – 2521
2025
Q1 		$190K Hold
28,748
– – ﹤0.01% 2324
2024
Q4 		$250K Buy
+28,748
New +$414K ﹤0.01% 2453
2023
Q4 		– Sell
-39,465
Closed -$359K – 2522
2023
Q3 		$359K Sell
39,465
-26,711
-40% -$271K ﹤0.01% 2249
2023
Q2 		$700K Sell
66,176
-10,848
-14% -$128K ﹤0.01% 2029
2023
Q1 		$942K Hold
77,024
– – ﹤0.01% 1822
2022
Q4 		$956K Sell
77,024
-64,201
-45% -$933K ﹤0.01% 1758
2022
Q3 		$1.93M Buy
141,225
+51,738
+58% +$798K 0.01% 1241
2022
Q2 		$1.64M Buy
+89,487
New +$1.29M ﹤0.01% 1370
2021
Q3 		– Sell
-14,300
Closed -$298K – 2485
2021
Q2 		$298K Sell
14,300
-30,827
-68% -$765K ﹤0.01% 2332
2021
Q1 		$1.27M Sell
45,127
-31,053
-41% -$982K ﹤0.01% 1724
2020
Q4 		$2.49M Buy
+76,180
New +$2.68M 0.01% 1180

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Thrivent Financial for Lutherans's KURA Position: Q4 2025 in Review

Thrivent Financial for Lutherans sold out of Kura Oncology (KURA) in Q4 2025, closing a stake of 58,951 shares — an estimated $521K sold.

Thrivent Financial for Lutherans first reported a position in KURA in Q4 2020 and held it in 12 quarters. The position peaked at $2.49M in Q4 2020. 215 funds tracked by Wall St. Rank hold KURA as of Q4 2025.

  • Thrivent Financial for Lutherans reported no remaining Kura Oncology position as of Q4 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 58,951 Kura Oncology shares in Q4 2025, an estimated $521K.
  • Thrivent Financial for Lutherans first reported a position in Kura Oncology in Q4 2020 and held it in 12 quarters.
  • Thrivent Financial for Lutherans's Kura Oncology position peaked at $2.49M in Q4 2020.
  • 215 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2025, filed 5 Feb 2026.